NASDAQ
Nautilus Biotechnology, Inc. (NAUT) has a free cash flow growth of -7.85% as of Friday, May 29, 2026. This represents a 357.71% decrease compared to its 12-month average of 3.05%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.